Chloro-s-triazines-toxicokinetic, toxicodynamic, human exposure, and regulatory considerations |
|
Author: | Abass, Khaled1,2; Pelkonen, Olavi3; Rautio, Arja1,4 |
Organizations: |
1Arctic Health, Faculty of Medicine, University of Oulu, Oulu, P.O. Box 7300, FI-90014, Finland 2Department of Pesticides, Menoufia University, P.O. Box 32511, Egypt 3Pharmacology and Toxicology Unit, Research Unit of Biomedicine, University of Oulu, P.O. Box 5000, FI-90014, Oulu, Finland
4Thule Institute, University of the Arctic, Rovaniemi, P.O. Box 7300, FI-90014, Finland
|
Format: | article |
Version: | published version |
Access: | open |
Online Access: | PDF Full Text (PDF, 1.7 MB) |
Persistent link: | http://urn.fi/urn:nbn:fi-fe202201189202 |
Language: | English |
Published: |
Bentham Science,
2021
|
Publish Date: | 2022-01-18 |
Description: |
AbstractChloro-s-triazines-atrazine, cyanazine, propazine, simazine, and terbuthylazine-are structurally similar herbicides, differing only in specific s-triazine4-and 6-N alkyl substituents. It is generally regarded that their toxicokinetics, such as, metabolic pathways, biological effects and toxicities, also share more similar features than the differences. Consequently, it is useful to compare their characteristics to potentially find useful structure-activity relationships or other similarities or differences regarding different active compounds, their metabolites, and biological effects including toxic outcomes. The ultimate goal of these exercises is to apply the summarized knowledge-as far as it is possible regarding a patchy and often inadequate database-to cross the in vitro-in vivo and animal-human borders and integrate the available data to enhance toxicological risk assessment for the benefit of humans and ecosystems. see all
|
Series: |
Current drug metabolism |
ISSN: | 1389-2002 |
ISSN-E: | 1875-5453 |
ISSN-L: | 1389-2002 |
Volume: | 22 |
Issue: | 8 |
Pages: | 645 - 656 |
DOI: | 10.2174/1389200222666210701164945 |
OADOI: | https://oadoi.org/10.2174/1389200222666210701164945 |
Type of Publication: |
A2 Review article in a scientific journal |
Field of Science: |
3111 Biomedicine |
Subjects: | |
Funding: |
This work was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825762-EDCMET and supported by a grant from Thule Institute, University of Oulu, Finland. |
EU Grant Number: |
(825762) EDCMET - Metabolic effects of Endocrine Disrupting Chemicals: novel testing METhods and adverse outcome pathways |
Copyright information: |
© The Author(s) 2021. This is an Open Access article published under CC BY 4.0 (https://creativecommons.org/licenses/by /4.0/legalcode).
|
https://creativecommons.org/licenses/by/4.0/ |